NYSE:NGVTChemicals
Ingevity (NGVT) Stock Looks Overvalued After A 29% Three Year Gain
Ingevity stock has delivered a 29.4% gain over the past three years, yet current valuation checks flag the shares as trading on the expensive side relative to earnings and cash flow, leaving investors weighing recent share price strength against a mixed overall value picture.
A 29.4% return over three years points to solid shareholder gains that can limit the margin of safety if future expectations are already reflected in the price.
Future cash generation from specialty chemicals and...